Clinical Trial Update: Efficacy of SENS-111 in Patients Suffering From Acute Unilateral Vestibulopathy [Phase 2]

View source ↗

Summary

Phase 2 trial assessing the efficacy of SENS-111 in Acute Unilateral Vestibulopathy has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Unilateral Vestibulopathy

Drugs mentioned

• SENS-111

Snippet

Sponsor: Sensorion | Conditions: Acute Unilateral Vestibulopathy (AUV) | Phase 2 | Status: COMPLETED | Results posted: 2020-10-27